Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Citius Management
Cranford, New Jersey, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
LYMPHIR (denileukin diftitox-cxdl) launched in the U.S. in December 2025 as the first new systemic therapy for cutaneous T-cell lymphoma since 2018, following FDA approval in August 2024. Mino-Lok completed a pivotal Phase 3 trial meeting primary and secondary endpoints. Halo-Lido completed Phase 2b; company is actively engaged with the FDA on next steps for both programs.
- Therapeutic areas
- OncologyGastroenterologyInfectious Diseases
- Modalities
- Fusion toxin protein therapySmall moleculeTopical formulation
- Industry
- Biotech
02
Partnerships
Three leading U.S. pharmaceutical wholesalers for LYMPHIR distributionRegional distribution partners for international named patient programsAI-powered sales and marketing platform providerGlobal commercialization services provider for medical information, pharmacovigilance, and revenue cycle management
Beyond the preview
Go deeper on Citius Management.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Citius Management.